Showing results (31-40 of 1,111) with videos related to

Sort By:
Pageof 112
Hepatobiliary Surgery and Nutrition|April 27, 2016
Intratumor heterogeneity, variability and plasticity: questioning the current concepts in classification and treatment of hepatocellular carcinomaRalf Weiskirchen
Cells|August 12, 2022
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"Ralf Weiskirchen
Cells|May 6, 2020
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"Ralf Weiskirchen
Cells|January 24, 2025
Topic "Signaling Pathways in Liver Disease"Ralf Weiskirchen
Medical Sciences (Basel, Switzerland)|January 21, 2026
Genetic Insights into the Economic Toll of Cell Line Misidentification: A Comprehensive ReviewRalf Weiskirchen
RSC Advances|November 17, 2025
Comment on "Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives" by J.-X. Lu, H.-R. Lan, D. Zeng, J.-Y. Song, Y.-T. Hao, A.-P. Xing, A. Shen, and J. Yuan, RSC Adv., 2025, 15, 231-243Ralf Weiskirchen
Research Integrity and Peer Review|July 10, 2025
Misidentified cell lines: failures of peer review, varying journal responses to misidentification inquiries, and strategies for safeguarding biomedical researchRalf Weiskirchen
Journal of Clinical Laboratory Analysis|July 6, 2018
Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patientsAlexander Koch, Eray Yagmur, Alexander Hoss, et al.
Analytical Cellular Pathology (Amsterdam)|August 11, 2015
Isolation and time lapse microscopy of highly pure hepatic stellate cellsMatthias Bartneck, Klaudia Theresa Warzecha, Carmen Gabriele Tag, et al.
Journal of Clinical Laboratory Analysis|June 5, 2018
High mobility group box 1 as a biomarker in critically ill patientsEray Yagmur, Lukas Buendgens, Ulf Herbers, et al.
Pageof 112